Blog Network Association Review

While straightforward economics may dictate that a pharmaceutical company’s bottom line is really driven by the need to sell its products for monetary gain, a more holistic view should be taken. The company is in a critical position, market wise in relation to government regulators and the end consumer. This dynamic environment is sometimes difficult to understand and pharmaceutical consultants can definitely benefit the company as it struggles to remain competitive.

FDA regulations require pharmaceutical companies to be in strict compliance, make use of established practices and all safety criteria as they produce products for final use. The importance of marketing in this environment should never be underestimated. The physician or pharmacist has to juggle a lot of information, much of it based on older science, together with the wants and needs of the patient and budgetary restrictions applied by insurance companies or individual positions.

If the patient is to be adequately catered to, it is important that lines of communication between pharmaceutical companies and professionals are open and clear and this is where marketing is so important. It follows that the standard of this marketing and its effectiveness directly contributes to the patient’s ability to live a longer, healthier and more productive life. It’s crucial to remember that these forms of marketing represent a two way street. The company must not only communicate the benefits and risks of its product to the professional, the reasoning and science behind its introduction and instructions for its use, but the professional must give real world feedback and crucial data to the company.

The contribution of pharma consulting should never be underestimated as it can help to emphasise how certain conditions can be treated by emerging products and help to reveal how other illnesses, previously under-served, could be addressed. Where treatment gaps may have previously existed, the research and work done by the pharmaceutical companies can also raise awareness and enable treatment for patients who may not have realised the treatment was available. Just because the pharmaceutical products may exist, it does not mean that these products will find their way into the hands of the consumer. Marketing plays a critical role in disseminating the information from one end of the chain to the other, into the hands of the professionals for communication with the patient.

Scientific breakthroughs enable the creation of products which are subsequently sanctioned by the government and this whole process focuses on the need for treatment of chronic illnesses. For example, certain side effects or by-products of a critical element may not have been apparent, or the link between illness and cure revealed, unless and until adequate marketing channels are open between the researchers, producers, professionals and patients.

In most instances, pharmaceutical consulting firms can also play a critical role in educating clients, producers and users. Their interaction, encouragement and foresight can help to ensure that the marketing machine is primed and key players are aware of each other’s vital contributions, so important in this hyper-competitive environment.

Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.